Home » Human Normal Pancreatic Primary Cell Culture - Frozen Vial
Human Normal Pancreatic Primary Cell Culture - Frozen Vial
Catalog Number : 36115-42N
Availability : In Stock
Price : $550.00
 

Related Products


  • Description
  • Publication
  • Documents

 Human Normal Pancreatic Primary Cell Culture - Frozen Vial

 
Source: Human Pancreatic Tissue
 
Positive Markers:  Pax8,ESA, GAD65,Foxa2, Sox17,HNF1Beta,Amylase, Carboxypeptidase A, Chymotrypsinogen B, Pdx1
 
Also Avaliable as:
 
T25 plated cells $550.00 shipped at room temperature. Cat#36115-42N-T25
T75 plated cells $750.00 shipped at room temperature. Cat#36115-42N-T75
 
T150 Plated Cells $2500.00 shipped at room temperature. Cat#36115-42N-T150
T225 Plated Cells $5500.00 shipped at room temperature. Cat#36115-42N-T225
 
120 Population doublings or up to 12 passages.
 
One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice.
 
This product would require pre-coated flasks with Human Normal Pancreatic Primary Cell Culture Complete Extra-cellular Matrix Cat# E36115-42N and Media with Serum Cat# M36115-45NS, and for serum free conditions M36115-42N is required provided the cells are weaned off the serum, as indicated in their specified protocol provided with purchase of these cells.
 
Cells are only guaranteed with purchase of Celprogen Media, Extra Cellular Matrix, Trypsin EDTA, 1X PBS, and freezing media for the appropriate cell culture, for 30 days from the date of shipment.
 
For non-academic use, please inquire for pricing.
 
1000 individual donors are fully characterized proprietary patient-derived xenografts (PDX) representing all major histotypes and capturing tumor diversity.
Subcutaneous, orthotopic and disseminated models.  Extensive molecular and pharmacological characterization as well as information on patients' pretreatment to help you select the most appropriate model.
Integrated approach: use the same PDX models and/or the corresponding cell line in 2D/3D screening assays and follow-up in vivo studies, identify biomarkers predicting tumor sensitivity for your compound.
Individually tailored study designs: proof of concept, dose level and schedule optimization, combinations, biomarker identification, etc.